Showing 41 - 60 results of 174 for search '"Lucentis"', query time: 0.12s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53
  14. 54

    Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019 by Ahmedalgabri RHM, Omer T, Zarroug F, Elkhawad AO, Noma M

    Published 2022-04-01
    “…The mean BCVA before and after treatment for both drugs respectively 0.19 min and 0.21 min was statistically correlated (p = 0.000). For patients under Lucentis, the mean BCVA before and after medication was 0.20 min– 0.24 min and 0.19– 0.19 min for those who used Avastin. …”
    Get full text
    Article
  15. 55

    Studies on sustained release platforms for delivery of therapeutic agents to the posterior segment of the eye by Joseph, Rini Rachel

    Published 2017
    “…Trans-scleral transport of Lucentis from different liposome-encapsulated formulations was compared with trans-scleral transport of bare-Lucentis and found to be slowed down in the case of encapsulated formulations. …”
    Get full text
    Thesis
  16. 56

    Study on ocular drug delivery system for treatment of posterior segment eye diseases by Tan, Sharon Kai Ling

    Published 2014
    “…ELISA and microBCA tests were carried out and results proved that degradation of Lucentis occurred over the 10 weeks of incubation. …”
    Get full text
    Final Year Project (FYP)
  17. 57

    Myopic Choroidal Neovascularization Membranes Treated With Ranibizumab in Colombian Population by Hernan Andres Rios, Anne Brieke, Shirley Rosenstiehl, Francisco Rodriguez

    Published 2017-01-01
    “…A loading dose of three monthly Ranibizumab (Lucentis®) injections were given to the recruited subjects. …”
    Get full text
    Article
  18. 58

    Biosimilars in ophthalmology: “Is there a big change on the horizon?” by Sharma A, Reddy P, Kuppermann BD, Bandello F, Loewenstein A

    Published 2018-10-01
    “…It is important for clinicians to have a clear understanding about ophthalmic biosimilars before the industry brings these molecules to the mainstream clinical use globally.Keywords: biosimilar, Razumab®, Lucentis®, Eylea®, ophthalmology…”
    Get full text
    Article
  19. 59

    Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion by Chong Zhang, Tong-Tong Niu

    Published 2016-04-01
    “…AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). …”
    Get full text
    Article
  20. 60

    The effects of anti-VEGF drugs on the retinal pigment epithelium and inner segment after intravitreal injection in the monkeys by Nan Su, Fu-Guang Li, Ulrich Schraermeyer

    Published 2016-06-01
    “…But at 7d, both Lucentis and Eylea have the same effect on reducing VEGF expression level in the RPE and inner segment.…”
    Get full text
    Article